Investor.exactsciences.com

  1. Home
  2. Investor.exactsciences.com

Exact Sciences Launches OncoExTra™ Cancer Therapy Selection …

WebExact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the launch of the OncoExTra™ therapy …

Actived: 3 days ago

URL: https://investor.exactsciences.com/investor-relations/press-releases/press-release-details/2023/Exact-Sciences-Launches-OncoExTra-Cancer-Therapy-Selection-Test-in-the-U.S/default.aspx

Exact Sciences Corporation

WebBLUE-C study met all endpoints, showing improved cancer sensitivity, specificity, and precancer sensitivity 20,000-participant study reflects racial and ethnic …

Category:  Cancer Go Health

Exact Sciences Corporation

WebSuccessful collaboration will continue to support Cologuard adoption through 2022 Exact Sciences Corp. (Nasdaq: EXAS) and Pfizer Inc. (NYSE: PFE) today …

Category:  Health Go Health

Investor Relations

WebShares Held % O/S Share Change Filing Date; The Vanguard Group, Inc. 17,175: 9.52: 164: 06/30/2023: JPMorgan Investment Management, Inc. 12,307: 6.82: 878: 06/30/2023

Category:  Health Go Health

Exact Sciences to Provide Mayo Clinic Patients with Individualized

WebInitiative advances precision cancer medicine by bringing comprehensive genomic profiling and hereditary cancer tests to patients at the Mayo Clinic …

Category:  Cancer,  Medicine Go Health

Exact Sciences Advances Innovative Cancer Technologies and …

WebExact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced separate collaborations with two …

Category:  Cancer Go Health

Exact Sciences Corporation

WebFinancials. Whitepaper: Blood-based CRC Assays. Genomic Health Form 8937. Paradigm Form 8937. Viomics Form 8937. Thrive Form 8937.

Category:  Health Go Health

Exact Sciences Corporation

WebMADISON, Wis. and CAMBRIDGE, Mass., Oct. 27, 2020 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) and Thrive Earlier Detection Corp. ("Thrive"), a …

Category:  Health Go Health

Exact Sciences Corporation

WebMADISON, Wis. and REDWOOD CITY, Calif., July 29, 2019 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) and Genomic Health, Inc. (NASDAQ: GHDX) …

Category:  Health Go Health

Exact Sciences Announces Fourth Quarter 2023 Results

WebReports record revenue, generates positive free cash flow, expects 2024 revenue of $2.810-2.850 billion Fourth quarter and 2023 highlights Total fourth quarter …

Category:  Health Go Health

Exact Sciences Completes Acquisition of Thrive Earlier Detection

WebExact Sciences Corp. (Nasdaq: EXAS) today announced that it has completed its previously announced acquisition of Thrive Earlier Detection Corp. ("Thrive"). …

Category:  Health Go Health

Exact Sciences Corporation

WebUltima Genomics, Inc. and Exact Sciences Corporation (Nasdaq: EXAS ) have entered a long-term supply agreement for Ultima's next-generation sequencing …

Category:  Health Go Health

Exact Sciences Acquires PreventionGenetics to Accelerate …

WebPreventionGenetics' comprehensive genetic testing portfolio complements Exact Sciences' advanced cancer tests, enabling disease prevention and earlier cancer …

Category:  Cancer Go Health

Exact Sciences Announces Fourth Quarter 2022 Results

WebExact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company generated revenue of …

Category:  Cancer Go Health

Exact Sciences Announces First Quarter 2023 Results

WebExact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company generated revenue of $602.5 million …

Category:  Cancer Go Health

Cologuard® Helps More People Get Screened In A Cost-Effective …

WebDr. Itzkowitz has been a consultant for Exact Sciences. Contact: Cara Connelly, Exact Sciences, 614-302-5622 [email protected]. About Exact …

Category:  Health Go Health

Exact Sciences Announces Third-Quarter 2023 Results

WebExact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company generated revenue of $628.3 …

Category:  Cancer Go Health

Exact Sciences Corporation

WebExact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced late-breaking data from the pivotal …

Category:  Cancer Go Health

Top Categories

 › Appendicitis

 › Headaches

 › Gout

 › Women's Health

 › Thyroid

 › Sleep

 › Skin

 › Sexual Health

 › Senior Health

 › Pregnancy

 › Oral Health

 › Neurology

 › Migraine

 › Mental Health

 › Men's Health

 › Menopause

 › Medications

 › Lung Conditions

 › Infectious Disease

 › HIV/AIDS

Popular Searched

 › Download wearhealth for windows 10

 › Mental health access ratings

 › Mt druitt community health centre

 › Heritage healthcare phone number

 › Best mental health services online

 › Http www.nhhealthcost.nh.gov

 › Health industry number verification

 › Uci health admin fellowship

 › Health insurance for lgbt people

 › Health industry number validation

Recently Searched

 › Clicsequr quebec health booklet

 › Health and fitness data store

 › Health concerns for military veterans

 › Epsom health walks map

 › Baptist health medical associates

 › Compare united health care plans

 › Kinetix health club macon

 › Washington state apple health replacement card

 › Mental health issues in science

 › Epsom health walks routes